Comparative studies of dipeptidyl peptidase 4 inhibitor vs sulphonylurea among Muslim Type 2 diabetes patients who fast in the month of Ramadan: A systematic review and meta-analysis
详细信息 查看全文
- 作者：Huai Heng Loha ; hh_loh@yahoo.com.my" class="auth_mail" title="E-mail the corresponding author ; Anne Yeeb ; Huai Seng Lohc ; Norlela Sukord ; Nor Azmi Kamaruddind
- 关键词：Dipeptidyl peptidase-4 inhibitor ; Ramadan fasting ; Sulphonylurea ; Type 2 diabetes mellitus
- 刊名：Primary Care Diabetes
- 出版年：2016
- 出版时间：June 2016
- 年：2016
- 卷：10
- 期：3
- 页码：210-219
- 全文大小：962 K
文摘
- •
DPP4 inhibitor has lower risk of hypoglycemia when used during fasting months.
- •
Vildagliptin has efficacy in glucose control which is comparable to sulphonylurea.
- •
DPP4 inhibitor is a safer alternative for Muslim patients with Type 2 diabetes.